Long-Term Survival and Value of (18)F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with (177)Lu-DOTATATE

Peptide receptor radionuclide therapy (PRRT) has been recognized as a promising therapy against neuroendocrine tumors (NETs). The use of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) in NETs has been a matter of controversy. The purpose of this study was to evaluate the lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Margarida, Winkler, Kevin-Klaus, Svirydenka, Hanna, Nilica, Bernhard, Uprimny, Christian, Virgolini, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000415/
https://www.ncbi.nlm.nih.gov/pubmed/33806393
http://dx.doi.org/10.3390/life11030198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000415/
https://www.ncbi.nlm.nih.gov/pubmed/33806393
http://dx.doi.org/10.3390/life11030198

Ejemplares similares